Crossmark

A systematic review of the association between delayed appropriate therapy and mortality among patients hospitalized with infections due to Klebsiella pneumoniae or Escherichia coli: how long is too long?

Crossref DOI link: https://doi.org/10.1186/s12879-018-3524-8

Published Online: 2018-12-05

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lodise, Thomas P.

Zhao, Qi

Fahrbach, Kyle

Gillard, Patrick J.

Martin, Amber
Funding

Funding for this research was provided by:

Allergan plc
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 9 August 2018

Accepted: 19 November 2018

First Online: 5 December 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: TPL has received consulting fees or honoraria and support for travel to meetings for this study or other purposes from Allergan plc. He has also been a consultant for Merck and The Medicines Company and has received payment for lectures including service on speakers bureaus for Allergan for work not associated with the current study. QZ was an employee of Allergan at the time of study conduct and analysis. KF and AM are employees of Evidera. Evidera received payment for conducting the analyses on which this study is based. PJG is an employee of Allergan and may hold stock or stock options.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below